Why the study?
Previous meta-analyses investigated lipid-lowering therapies for atherosclerotic cardiovascular disease, but few focused specifically on patients with ACS.
Does intensive lipid-lowering therapy reduce three-point MACE in patients with prior ACS compared to background statin therapy?
Does intensive lipid-lowering therapy reduce three-point MACE in patients with prior ACS compared to background statin therapy?
Intensive lipid-lowering therapies added to background statin therapy may reduce the risk of MACE and recurrent cardiovascular events in patients with ACS.
Answers are grounded in this paper and cite their sources.
May support intensified lipid-lowering post-ACS; extends low-certainty evidence from three trials.
BACKGROUND: Previous meta-analyses have investigated the efficacy of lipid-lowering therapies for atherosclerotic cardiovascular disease; however, few have focused on patients with acute coronary syndrome (ACS). This meta-analysis aimed to compare the benefits of intensive lipid-lowering therapy with those of background statin therapy in patients with ACS. METHODS: Searches were performed on PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases for articles published until April 13, 2023. Randomized controlled trials that compared intensive lipid-lowering therapies and background statin therapies in patients with prior ACS and recorded the outcome of three-point major cardiovascular events (MACE) were included. The risk ratio (RR) with 95% confidence interval (CI) was used as a measure of primary and secondary outcomes. CONCLUSIONS: Intensive lipid-lowering therapies may reduce the risk of three-point MACE, recurrent ACS, nonfatal MI, stroke, and hospitalization for unstable angina in patients with ACS undergoing background statin therapy. These results may assist in clinical decision-making for the secondary prevention of cardiovascular events to initiate intensive lipid-lowering therapies immediately after ACS.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: